CBIS Expands Licensing Deal with Purple Haze Properties as it Launches 'Jimi's Cannabis Collection' Today at the Chicago 'Marijuana Business Conference and Expo'

Visit Andrew Pitsicalis, CEO of Purple Haze Properties, Today in Chicago, Representing Individual & Joint Medicinal Products Created with CBIS for 'Jimi's Cannabis Collection' Including Genetic Strains & Products

COLORADO SPRINGS, Colo., May 19, 2015 /PRNewswire/ -- Cannabis Science, Inc. CBIS, a U.S. company specializing in cannabis formulation-based drug development and related consulting, today announced that Purple Haze Properties CEO Andrew Pitsicalis will be representing individual and joint medicinal products created with CBIS for "Jimi's Cannabis Collection" including genetic strains and products at the Chicago "Marijuana Business Conference and Expo." Cannabis Science and Purple Haze Properties are working together to launch exciting lines of quality cannabis products using scientific genetics and creating an education platform to share information from doctors and patients around the world about the advances of cannabis research.

Purple Haze Properties will be launching its concept of the Purple Haze Lounges worldwide and will be looking at Denver and Los Angeles for the first ground breaking locations and then Jamaica and Vancouver, B.C, as potential international future locations. These 20,000 sq. ft. "Ultra Lounges" will have a concert hall, restaurants, VIP memberships and charity foundation with themed social areas. We want to give the patron and performer an amazing cultural experience. The property will utilize the best music and video technologies and have some of the finest functional glass art ever seen.

Making its debut is the launch of Jimi's Cannabis Collection, a lifestyle brand dedicated to the greatest guitarist in rock and roll history. We decided to launch our brand at the "Marijuana Business Conference and Expo" today in Chicago, "America's oldest and largest national cannabis trade show." Purple Haze Properties is launching Jimi's Cannabis Collection of strains, edibles, and medical CBD topical creams, lotions and throat spray. The medical line will aid in relieving symptoms, such as pain management for throat issues, scars, burns and skin cancer. Jimi's three divisions will cover major areas of the cannabis industry. "Jimi's Genetix" is the division for strains and concentrates. "Jimi's Edibles" is the division of consumable products and "Jimi's Meds" is for non-psychoactive, CBD & Cannabinoid, pharmacy grade, topical throat, and pain management solutions.

Cannabis Science will help Purple Haze educate people by having kiosks in the facilities to educate self-medicating patients, to inform about historical cannabis diagnosed ailments and conditions. The high tech kiosk displays will provide educational access to consumers in regards to historical prescriptions, historical and relative strain and dosage for ailments. It will also provide the public with historical and scientific information about cannabinoids and other elements contained in the plant. This up to date information provided by CBIS will inform the patron about advances in research that are allowing cannabis to battle crippling diseases we face today.

As Cannabis Science does not support smoking as a delivery mechanism or advocate for recreational use, CBIS will help Purple Haze Properties in the creation of pharmaceutical grade CBD products for Jimi's Cannabis Collection. The goal is to help those patients find a natural alternative to pharmaceutical drugs prescribed today. Jimi's Cannabis Collection will be giving a portion of its proceeds from sales of its products to help in scientific research to help find effective treatments for AIDS, various cancers, PTSD, and other health traumas. These donations from Jimi's Cannabis Collection will go to CBIS, Cannabis Science, Inc. CBIS takes advantage of its unique understanding of metabolic processes to provide innovative treatment options for unmet medical needs.

Purple Haze Properties CEO and President Andrew Pitsicalis stated, "We are very pleased to be working with Cannabis Science and licensing our brand to additional companies worldwide. We will license to those who have the legal rights to produce, cultivate and dispense cannabis in medical or recreational states nationwide. We also have plans to expand to over 25 countries, which have legalized or decriminalized Cannabis."

The option to license the Brand by state and territory is now available. The brand's platform will give fans of Hendrix the great energy, spirit, and vibration that Jimi gave to the world in his music. Patients will be able to scan in QR codes on product packaging for "cool, free give-aways" of Jimi Hendrix T-shirts, art and merchandise. If you're interested in licensing a territory or one of the branded product lines or for more information, contact Purple Haze Properties at 1-800-291-3239 or Email inquiries to purplehazeprop@gmail.com.

About Cannabis Science, Inc.

Cannabis Science, Inc., takes advantage of its unique understanding of metabolic processes to provide novel treatment approaches to a number of illnesses for which current treatments and understanding remain unsatisfactory. Cannabinoids have an extensive history dating back thousands of years, and currently, there are a growing number of peer-reviewed scientific publications that document the underlying biochemical pathways that cannabinoids modulate. The Company works with leading experts in drug development, medicinal characterization, and clinical research to develop, produce, and commercialize novel therapeutic approaches for the treatment for illnesses caused by infections as well as for age-related illness. Our initial focus is on skin cancers, HIV/AIDS, and neurological conditions.  The Company is proceeding with the research and development of its proprietary drugs as a part of this initial focus:  CS-S/BCC-1, CS-TATI-1, and CS-NEURO-1, respectively.

Purple Haze Properties
Andrew Pitsicalis
President & CEO
1-800-291-3239
purplehazeprop@gmail.com

Cannabis Science, Inc.
Raymond C. Dabney
President & CEO, Co-Founder
info@cannabisscience.com
Tel: 1.888.889.0888
www.cannabisscience.com

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cbis-expands-licensing-deal-with-purple-haze-properties-as-it-launches-jimis-cannabis-collection-today-at-the-chicago-marijuana-business-conference-and-expo-300085648.html

SOURCE Cannabis Science, Inc.

Posted In: Press Releases

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.